RecruitingNCT07062016

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

MC230601 Molecular and ctDNA Characterization of High-Risk Endometrial Cancer


Sponsor

Mayo Clinic

Enrollment

100 participants

Start Date

Oct 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study seeks to better understand the recurrence of high-risk endometrial cancer. It will collect information about cancer genetics to find out various hereditary or cancer specific genetic variants that may have a role in diagnosis or management and prognosis of cancer. It also seeks to develop a genetic results and medical record databank for future studies.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects tumor samples and blood (including circulating tumor DNA) from people with high-risk endometrial (uterine) cancer to better understand what drives aggressive disease and help develop more targeted future treatments. **You may be eligible if...** - You are 18 years or older - You are scheduled for complete surgical staging for endometrial cancer at Mayo Clinic (including removal of the uterus and ovaries, and lymph node evaluation) - Your cancer has features suggesting it is high-risk — such as high-grade tissue on biopsy, deep tumor invasion into the uterine wall, large tumor size, or certain aggressive cancer subtypes **You may NOT be eligible if...** - You are not having surgery at Mayo Clinic - Your cancer does not have high-risk features - You are unable to consent to the research procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07062016


Related Trials